Subclonal TP53 and KRAS Variants Combined with Poor Treatment Response Identify Ultra-High-risk Pediatric T-ALL Patients
Blood Advances(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined